Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
C D Constantinou, … , K B Nielsen, D J Prockop
C D Constantinou, … , K B Nielsen, D J Prockop
Published February 1, 1989
Citation Information: J Clin Invest. 1989;83(2):574-584. https://doi.org/10.1172/JCI113920.
View: Text | PDF
Research Article

A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.

  • Text
  • PDF
Abstract

A fraction of the pro alpha 1(I) and pro alpha 2(I) chains in type I procollagen synthesized by the fibroblasts from a proband with a lethal variant of osteogenesis imperfecta were overmodified by posttranslational reactions. After digestion with pepsin, some of the alpha 1(I) chains were recovered as disulfide-linked dimers. Mapping of cyanogen bromide peptides indicated that the disulfide link was contained in alpha 1-CB6, the cyanogen bromide fragment containing amino acid residues 823-1014 of the alpha 1(I) chain. Nucleotide sequencing of cDNA clones demonstrated a substitution of T for G that converted glycine 904 of the alpha 1(I) chain to cysteine. A large fraction of the type I procollagen synthesized by the proband's fibroblasts had a thermostability that was 3-4 degrees C lower than the normal type I procollagen as assayed by brief proteinase digestion. In addition, the type I procollagen synthesized by the proband's fibroblasts was secreted with an abnormal kinetic pattern in that there was a lag period of about 30 min in pulse-chase experiments. The mutation of glycine to cysteine was not found in type I procollagen synthesized by fibroblasts from the proband's parents. Therefore, the mutation was a sporadic one. However, the mother's fibroblasts synthesized a type I procollagen in which part of the pro alpha chains were overmodified and had a lower thermostability. Therefore, the proband may have inherited a mutated allele for type I procollagen from her mother that contributed to the lethal phenotype. The mother was asymptomatic. She was somewhat short and had slightly blue sclerae but no definitive signs of a connective tissue abnormality. The observations on the mother indicated, therefore, that a mutation that causes synthesis of a type I procollagen with a lowered thermal stability does not necessarily produce a heritable disorder of connective tissue.

Authors

C D Constantinou, K B Nielsen, D J Prockop

×

Total citations by year

Year: 2021 2014 2013 2011 2007 2005 2004 2000 1999 1995 1994 1993 1992 1991 1990 1989 Total
Citations: 1 1 1 1 1 1 1 1 3 2 2 5 8 8 14 7 57
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (57)

Title and authors Publication Year
A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome
C Odiatis, I Savva, M Pieri, P Ioannou, P Petrou, G Papagregoriou, K Antoniadou, N Makrides, C Stefanou, DG Ljubanović, G Nikolaou, DB Borza, K Stylianou, O Gross, C Deltas
2021
Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies
O Gross, L Perin, C Deltas
Nephrology Dialysis Transplantation 2014
Autosomal Recessive Osteogenesis Imperfecta: A Puzzle for Bone Formation, Structure and Function
SP Boudko, EN Pokidysheva, HP Bächinger
Current Genetic Medicine Reports 2013
Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8
H Kaneko, H Kitoh, T Matsuura, A Masuda, M Ito, M Mottes, F Rauch, N Ishiguro, K Ohno
Human Genetics 2011
Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood
F Malfait, S Symoens, JD Backer, T Hermanns-Lê, N Sakalihasan, CM Lapière, P Coucke, AD Paepe
Human Mutation 2007
Role of Adult Mesenchymal Stem Cells in Bone Tissue Engineering Applications: Current Status and Future Prospects
JR Mauney, V Volloch, DL Kaplan
Tissue Engineering 2005
High Proportion of Mutant Osteoblasts Is Compatible with Normal Skeletal Function in Mosaic Carriers of Osteogenesis Imperfecta* *Presented as a platform presentation at the National Meeting of the American Society of Bone and Mineral Research (Late-Breaking Research Session), San Antonio, TX, September 2002
WA Cabral, JC Marini
The American Journal of Human Genetics 2004
Osteogenesis Imperfecta
F Antoniazzi, M Mottes, P Fraschini, PC Brunelli, L Tat??
Paediatric Drugs 2000
Osteogenesis imperfecta calls for caution-first letter
JC Marini
Nature Medicine 1999
Osteogenesis imperfecta calls for caution-second letter
NJ Bishop
Nature Medicine 1999
Reply to osteogenesis imperfecta calls for caution
EM Horwitz, DJ Prockop, LA Fitzpatrick, WW Koo, JC Marx, MK Brenner
Nature Medicine 1999
Osteogenesis Imperfecta, Rehabilitation Medicine, Fundamental Research and Mesenchymal Stem Cells
AI Caplan
Connective Tissue Research 1995
Tissue-specific Expression of the Gene for Type I Procollagen (COL1A1) in Transgenic Mice: ONLY 476 BASE PAIRS OF THE PROMOTER ARE REQUIRED IF COLLAGEN GENES ARE USED AS REPORTERS
BP Sokolov, L Ala-Kokko, R Dhulipala, M Arita, JS Khillan, DJ Prockop
The Journal of biological chemistry 1995
Molecular Genetic Techniques for Prenatal Diagnosis
K SUZUMORI, M TANEMURA, R ADACHI
Congenital Anomalies 1994
Self-assembly of collagen I from a proband homozygous for a mutation that substituted serine for glycine at position 661 in the alpha 2(I) chain. Possible relationship between the effects of mutations on critical concentration and the severity of the phenotype
AM Romanic, LD Spotila, E Adachi, J Engel, Y Hojima, DJ Prockop
The Journal of biological chemistry 1994
Osteogenesis imprefecta and type-I collagen mutations. A lethal variant caused by a Gly910Ala substitution in the alpha1(I) chain
M VALLI, A SANGALLI, A ROSSI, M MOTTES, A FORLINO, R TENNI, PF PIGNATTI, G CETTA
European Journal of Biochemistry 1993
Somatic cell mosaicism: Another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfecta
CD Constantinou-Deltas, RL Ladda, DJ Prockop
American Journal of Medical Genetics 1993
A Cysteine for Glycine Substitution at Position 175 in an α1 (I) Chain of Type I Collagen Produces A Clinically Heterogeneous Form of Osteogenesis Imperfecta
MK Wirtz, VH Rao, RW Glanville, ME Labhard, PJ Pretorius, WN de Vries, WJ de Wet, DW Hollister
Connective Tissue Research 1993
Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring
DM Milewicz, AM Witz, AC Smith, DK Manchester, G Waldstein, PH Byers
The American Journal of Human Genetics 1993
Deletion of 19 base pairs in intron 13 of the gene for the pro?2(I) chain of type-I procollagen (COL1A2) causes exon skipping in a proband with type-I osteogenesis imperfecta
J Zhuang, G Tromp, H Kuivaniemi, K Nakayasu, DJ Prockop
Human Genetics 1993
An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen
JR Shapiro, ML Stover, VE Burn, MB McKinstry, AL Burshell, SD Chipman, DW Rowe
Journal of Clinical Investigation 1992
Expression of mutant α(I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV
SD Chipman, JR Shapiro, MB McKinstry, ML Stover, P Branson, DW Rowe
Journal of Bone and Mineral Research 1992
Molecular nosology of heritable disorders of connective tissue
P Beighton, AD Paepe, JG Hall, DW Hollister, FM Pope, RE Pyeritz, B Steinmann, P Tsipouras
American Journal of Medical Genetics 1992
Lethal perinatal osteogenesis imperfecta due to a type I collagen α2(I) gly to arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch
JF Bateman, I Moeller, M Hannagan, D Chan, WG Cole
Human Mutation 1992
Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients
M Mörike, RE Brenner, GB Bushart, WM Teller, U Vetter
Biochemical Journal 1992
Comparative study on the thermostability of collagen I of skin and bone: Influence of posttranslational hydroxylation of prolyl and lysyl residues
H Notbohm, S Mosler, M Bodo, C Yang, H Lehmann, B Btge, PK Mller
Journal of Protein Chemistry 1992
The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen
WG Cole, E Patterson, J Bonadio, PE Campbell, DW Fortune
Journal of medical genetics 1992
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine ?1(I) 901 substitution in a type-I collagen gene
M Mottes, A Sangalli, M Valli, MG Lira, R Tenni, P Buttitta, PF Pignatti, G Cetta
Human Genetics 1992
Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production
PK Mays, RJ McAnulty, JS Campa, GJ Laurent
Biochemical Journal 1991
Osteogenesis imperfecta: translation of mutation to phenotype
PH Byers, GA Wallis, MC Willing
Journal of medical genetics 1991
Substitution of cysteine for glycine at residue 415 of one allele of the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis imperfecta
AC Nicholls, J Oliver, DV Renouf, M Keston, FM Pope
Journal of medical genetics 1991
A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain
M Valli, M Mottes, R Tenni, A Sangalli, MG Lira, A Rossi, F Antoniazzi, G Cetta, PF Pignatti
The Journal of biological chemistry 1991
The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix
RJ Wenstrup, AW Shrago-Howe, LW Lever, CL Phillips, PH Byers, DH Cohn
The Journal of biological chemistry 1991
A 9-base pair deletion in COL1A1 in a lethal variant of osteogenesis imperfecta
JR Hawkins, A Superti-Furga, B Steinmann, R Dalgleish
The Journal of biological chemistry 1991
Dominant mutations in familial lethal and severe osteogenesis imperfecta
L Cohen-Solal, J Bonaventure, P Maroteaux
Human Genetics 1991
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta
R Tenni, P Biglino, K Dyne, A Rossi, M Filocamo, F Pendola, P Brunelli, P Buttitta, C Borrone, G Cetta
Journal of Inherited Metabolic Disease 1991
A Substitution of Cysteine for Glycine 904 in COL1A1 in a Proband with Lethal Osteogenesis Imperfecta and in Her Asymptomatic Mother
CD Constantinou, MA Pack, SB Young, DJ Prockop
Annals of the New York Academy of Sciences 1990
Brittle bones - fragile molecules: disorders of collagen gene structure and expression
PH Byers
Trends in Genetics 1990
Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta
RJ Wenstrup, MC Willing, BJ Starman, PH Byers
The American Journal of Human Genetics 1990
Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent
GA Wallis, BJ Starman, AB Zinn, PH Byers
The American Journal of Human Genetics 1990
Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1)
CD Constantinou, M Pack, SB Young, DJ Prockop
The American Journal of Human Genetics 1990
The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues
WG Cole, PE Campbell, JG Rogers, JF Bateman
Journal of medical genetics 1990
Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids
DK Grange, GS Gottesman, MB Lewis, JC Marini
Nucleic Acids Research 1990
Anomalous Cysteine in Type I Collagen. Localisation by Chemical Cleavage of the Protein Using 2-Nitro-5-Thiocyanobenzoic Acid and by Mismatch Analysis of cDNA Heteroduplexes
R Tenni, A Rossi, M Valli, M Mottes, PF Pignatti, G Cetta
Matrix 1990
Bone and Mineral Research
A Perault-Staub, J Staub, G Milhaud
Bone and Mineral Research 1990
Extracellular Matrix Genes
LJ Sandell, CD Boyd
Extracellular Matrix Genes 1990
Connective Tissue Diseases in the Skin: From Molecules to Symptoms
T Krieg, M Aumailley
The Journal of Dermatology 1990
Clinical Screening for Collagen Defects in Connective Tissue Diseases
DH Cohn, PH Byers
Clinics in Perinatology 1990
Advances in Human Genetics
H Harris, K Hirschhorn
1990
The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen
WG Cole, CW Chow, JG Rogers, JF Bateman
Journal of medical genetics 1990
Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype
BJ Starman, D Eyre, H Charbonneau, M Harrylock, MA Weis, L Weiss, JM Graham, PH Byers
Journal of Clinical Investigation 1989
Prenatal diagnosis and prevention of inherited abnormalities of collagen
FM Pope, SC Daw, P Narcisi, AR Richards, AC Nicholls
Journal of Inherited Metabolic Disease 1989
Inherited disorders of collagen gene structure and expression
PH Byers
American Journal of Medical Genetics 1989
Type I procollagen: The gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue
DJ Prockop, CD Constantinou, KE Dombrowski, Y Hojima, KE Kadler, H Kuivaniemi, G Tromp, BE Vogel
American Journal of Medical Genetics 1989
Osteogenesis imperfecta type IV
JC Marini, DK Grange, GS Gottesman, MB Lewis, DA Koeplin
The Journal of biological chemistry 1989
Substitution of Serine for α1(I)-Glycine 844 in a Severe Variant of Osteogenesis Imperfecta Minimally Destabilizes the Triple Helix of Type I Procollagen
M Pack, CD Constantinou, K Kalia, KB Nielsen, DJ Prockop
The Journal of biological chemistry 1989
A Single Base Mutation That Substitutes Serine for Glycine 790 of the α 1 (III) Chain of Type III Procollagen Exposes an Arginine and Causes Ehlers-Danlos Syndrome IV
G Tromp, H Kuivaniemi, H Shikata, DJ Prockop
The Journal of biological chemistry 1989

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts